Kynam Capital Management

Latest statistics and disclosures from Kynam Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Kynam Capital Management

Companies in the Kynam Capital Management portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Global Blood Therapeutics In (GBT) 15.0 $46M 1.3M 34.64
Natera (NTRA) 12.8 $39M 966k 40.68
Syndax Pharmaceuticals (SNDX) 10.9 $34M 1.9M 17.38
Celldex Therapeutics Com New (CLDX) 8.3 $26M 753k 34.06
Travere Therapeutics (TVTX) 7.3 $22M 871k 25.77
Gossamer Bio (GOSS) 5.2 $16M 1.8M 8.68
Xenon Pharmaceuticals (XENE) 4.8 $15M 483k 30.57
Vaxcyte (PCVX) 4.5 $14M 580k 24.15
Vera Therapeutics Cl A (VERA) 3.8 $12M 502k 23.49
Miragen Therapeutics (VRDN) 3.5 $11M 590k 18.49
Liquidia Corporation Com New (LQDA) 2.7 $8.3M 1.2M 7.18
Biogen Idec (BIIB) 2.6 $8.1M 38k 210.61
Amarin Corp Spons Adr New (AMRN) 2.4 $7.5M 2.3M 3.29
Burning Rock Biotech Sponsored Ads (BNR) 2.3 $7.2M 773k 9.29

Setup an alert

Kynam Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Sierra Oncology Com New (SRRA) 2.0 $6.2M 193k 32.05
Centessa Pharmaceuticals Sponsored Ads (CNTA) 1.9 $6.0M 669k 8.97
Amicus Therapeutics (FOLD) 1.8 $5.4M 574k 9.47
Wave Life Sciences SHS (WVE) 1.2 $3.8M 1.9M 2.00
Fate Therapeutics (FATE) 1.1 $3.5M 91k 38.77
Merus N V (MRUS) 1.0 $3.1M 117k 26.44
Seres Therapeutics (MCRB) 0.7 $2.1M 291k 7.12
Puma Biotechnology (PBYI) 0.6 $1.9M 653k 2.88
Akouos (AKUS) 0.6 $1.8M 388k 4.75
Radius Health Com New (RDUS) 0.5 $1.6M 186k 8.83
Affimed Therapeutics B V (AFMD) 0.5 $1.5M 348k 4.37
Cabaletta Bio (CABA) 0.4 $1.3M 616k 2.03
Krystal Biotech (KRYS) 0.4 $1.2M 18k 66.55
Olema Pharmaceuticals (OLMA) 0.4 $1.2M 281k 4.26
Connect Biopharma Hldgs Ads (CNTB) 0.2 $688k 228k 3.02
Tg Therapeutics Put Option (TGTX) 0.1 $401k 259k 1.55
Neoleukin Therapeutics (NLTX) 0.1 $264k 141k 1.88
Nektar Therapeutics Put Option (NKTR) 0.1 $260k 200k 1.30
Catalyst Biosciences Com New (CBIO) 0.0 $70k 106k 0.66

Past Filings by Kynam Capital Management

SEC 13F filings are viewable for Kynam Capital Management going back to 2022